Depressive Syndrome Clinical Trial
Official title:
The Assessment of Osteoporosis Treatment in Post-menopausal Women
The study will be conducted to assess the depressive symptoms and related markers in the postmenopausal female after anti-osteoporosis treatment.
Fracture is one of the important complications in female. Osteoporosis should be treated in postmenopausal female due to high risk of fracture. Recently, there have been many classes of medications developed for preventing bone loss. Raloxifene, an oral form of anti-osteoporosis medication, has been reported to improved central nervous disorders. Therefore, this study is designed to assess the depressive symptoms and related markers in the postmenopausal female after anti-osteoporosis treatment. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00247429 -
Study Evaluating Venlafaxine Extended Release in Elderly Depressed Patients
|
Phase 4 | |
| Recruiting |
NCT06104696 -
Comprehensive Geriatric Assessment in Kidney Transplantation
|
||
| Unknown status |
NCT00229333 -
Study of Escitalopram Versus Placebo in the Treatment of Depressive Syndrome in Alzheimer’s Disease, Vascular Dementia, and Mixed Vascular and Alzheimer’s Dementia
|
Phase 4 |